Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Immunovant Inc.

    NASDAQ: IMVT · Real-Time Price · USD
    15.48
    -0.18 (-1.15%)
    At close: Jun 16, 2025, 3:59 PM
    15.49
    0.06%
    Pre-market: Jun 17, 2025, 04:33 AM EDT

    Immunovant Statistics

    Share Statistics

    Immunovant has 170.92M shares outstanding. The number of shares has increased by 16.2% in one year.

    Shares Outstanding

    n/a
    		 170.92M

    Shares Change (YoY)

    n/a
    		 16.2%

    Shares Change (QoQ)

    n/a
    		 15.72%

    Owned by Institutions (%)

    n/a
    		 54.54%

    Shares Floating

    n/a
    		 68.57M

    Failed to Deliver (FTD) Shares

    n/a
    		 1,497

    FTD / Avg. Volume

    n/a
    		 0.08%

    Short Selling Information

    The latest short interest is 21.68M, so 12.68% of the outstanding shares have been sold short.

    Short Interest

    n/a
    		 21.68M

    Short % of Shares Out

    n/a
    		 12.68%

    Short % of Float

    n/a
    		 24.48%

    Short Ratio (days to cover)

    n/a
    		 19.08

    Valuation Ratios

    The PE ratio is -6.26 and the forward PE ratio is -5.47. Immunovant's PEG ratio is -0.14.

    PE Ratio

    n/a
    		 -6.26

    Forward PE

    n/a
    		 -5.47

    PS Ratio

    n/a
    		 0

    Forward PS

    n/a
    		 1.6

    PB Ratio

    n/a
    		 3.66

    P/FCF Ratio

    n/a
    		 -6.88

    PEG Ratio

    n/a
    		 -0.14
    Financial Ratio History

    Enterprise Valuation

    Currently the Enterprise Value (EV) is not available for Immunovant.

    EV / Sales

    n/a
    		 n/a

    EV / EBITDA

    n/a
    		 n/a

    EV / EBIT

    n/a
    		 n/a

    EV / FCF

    n/a
    		 n/a

    Financial Position

    The company has a current ratio of 11.16, with a Debt / Equity ratio of 0.

    Current Ratio

    n/a
    		 11.16

    Quick Ratio

    n/a
    		 11.16

    Debt / Equity

    n/a
    		 0

    Debt / EBITDA

    n/a
    		 n/a

    Debt / FCF

    n/a
    		 n/a

    Interest Coverage

    n/a
    		 0

    Financial Efficiency

    Return on Equity is n/a and Return on Invested Capital is n/a.

    Return on Equity

    n/a
    		 n/a

    Return on Assets

    n/a
    		 n/a

    Return on Invested Capital

    n/a
    		 n/a

    Revenue Per Employee

    n/a
    		 n/a

    Profits Per Employee

    n/a
    		 $-1,143,204.42

    Employee Count

    n/a
    		 362

    Asset Turnover

    n/a
    		 0

    Inventory Turnover

    n/a
    		 n/a

    Taxes

    Income Tax

    n/a
    		 891K

    Effective Tax Rate

    n/a
    		 -0.22%

    Stock Price Statistics

    The stock price has increased by -42.24% in the last 52 weeks. The beta is 0.61, so Immunovant's price volatility has been higher than the market average.

    Beta

    n/a
    		 0.61

    52-Week Price Change

    n/a
    		 -42.24%

    50-Day Moving Average

    n/a
    		 14.95

    200-Day Moving Average

    n/a
    		 22.76

    Relative Strength Index (RSI)

    n/a
    		 50.52

    Average Volume (20 Days)

    n/a
    		 1,786,925

    Income Statement

    Revenue

    n/a
    		 n/a

    Gross Profit

    n/a
    		 n/a

    Operating Income

    n/a
    		 -438.15M

    Net Income

    n/a
    		 -413.84M

    EBITDA

    n/a
    		 n/a

    EBIT

    n/a
    		 n/a

    Earnings Per Share (EPS)

    n/a
    		 -2.73
    Full Income Statement

    Balance Sheet

    The company has 713.97M in cash and 98K in debt, giving a net cash position of 713.87M.

    Cash & Cash Equivalents

    n/a
    		 713.97M

    Total Debt

    n/a
    		 98K

    Net Cash

    n/a
    		 713.87M

    Retained Earnings

    n/a
    		 -1.24B

    Total Assets

    n/a
    		 776.22M

    Working Capital

    n/a
    		 698.89M
    Full Balance Sheet

    Cash Flow

    In the last 12 months, operating cash flow was -375.87M and capital expenditures -759K, giving a free cash flow of -376.63M.

    Operating Cash Flow

    n/a
    		 -375.87M

    Capital Expenditures

    n/a
    		 -759K

    Free Cash Flow

    n/a
    		 -376.63M

    FCF Per Share

    n/a
    		 -2.48
    Full Cash Flow Statement

    Margins

    Gross Margin

    n/a
    		 n/a

    Operating Margin

    n/a
    		 n/a

    Pretax Margin

    n/a
    		 n/a

    Profit Margin

    n/a
    		 n/a

    EBITDA Margin

    n/a
    		 n/a

    EBIT Margin

    n/a
    		 n/a

    FCF Margin

    n/a
    		 n/a

    Dividends & Yields

    IMVT does not appear to pay any dividends at this time.

    Dividend Per Share

    n/a
    		 n/a

    Dividend Yield

    n/a
    		 n/a

    Dividend Growth (YoY)

    n/a
    		 n/a

    Payout Ratio

    n/a
    		 n/a

    Earnings Yield

    n/a
    		 n/a

    FCF Yield

    n/a
    		 n/a
    Dividend Details

    Analyst Forecast

    The average price target for IMVT is $45, which is 190.7% higher than the current price. The consensus rating is "Buy".

    Price Target

    n/a
    		 $45

    Price Target Difference

    n/a
    		 190.7%

    Analyst Consensus

    n/a
    		 Buy

    Analyst Count

    n/a
    		 10
    Stock Forecasts

    Fair Value

    There are several formulas that can be used to estimate the intrinsic value of a stock.

    Lynch Fair Value

    n/a
    		 n/a

    Lynch Upside

    n/a
    		 n/a

    Graham Number

    n/a
    		 n/a

    Graham Upside

    n/a
    		 n/a

    Scores

    Altman Z-Score

    n/a
    		 19.1

    Piotroski F-Score

    n/a
    		 1

    Add to Watchlist